Related Experiment Video
Updated: Jul 3, 2026

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
Gadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathy
Antonio Romero-Puche1, Francisco Marín, Josefa González-Carrillo
1Servicio de Cardiología, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
Insights
Myocardial fibrosis detected by cardiac magnetic resonance is linked to reduced exercise capacity in hypertrophic cardiomyopathy patients. This finding highlights fibrosis as a key indicator of functional limitation.
Area of Science:
- Cardiology
- Medical Imaging
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease.
- Traditional markers of HCM are insufficient for predicting functional disability.
- Gadolinium-enhanced cardiovascular magnetic resonance (CMR) can detect myocardial fibrosis.
Purpose of the Study:
- To investigate the association between the extent of myocardial fibrosis, identified by CMR, and exercise capacity in HCM patients.
- To determine if fibrosis is a predictor of functional limitation in HCM.
Main Methods:
- 98 HCM patients underwent CMR, echocardiography, exercise testing, and Holter monitoring.
- Myocardial fibrosis was quantified as the percentage of myocardium with late gadolinium enhancement on CMR.
- Exercise capacity was measured in metabolic equivalent (MET) units.
Main Results:
- Late gadolinium enhancement was present in 68.4% of patients.
- Patients with fibrosis had significantly lower exercise capacity (8.04 METs vs. 10.41 METs, P=.003).
- A significant inverse correlation was found between fibrosis percentage and exercise capacity (r=-0.21, P=.044).
- N-terminal probrain natriuretic peptide (NT-proBNP) was the strongest predictor of exercise capacity.
- Multivariate analysis identified age, atrial fibrillation history, NT-proBNP, and fibrosis as independent predictors of exercise capacity.
Conclusions:
- Late gadolinium enhancement on CMR is independently associated with reduced exercise capacity in HCM.
- Myocardial fibrosis is a significant imaging biomarker for functional impairment in HCM.
- CMR-detected fibrosis provides valuable prognostic information in hypertrophic cardiomyopathy.
Introduction And Objectives:
Using gadolinium-enhanced cardiovascular magnetic resonance, it is possible to evaluate the presence of myocardial fibrosis in hypertrophic cardiomyopathy. Classical disease markers are weak predictors of functional disability in affected patients. Our objective was to study the relationship between the degree of myocardial fibrosis observed by cardiac magnetic resonance and exercise capacity.
Methods:
We performed cardiac magnetic resonance, echocardiography, exercise testing and Holter monitoring, along with the usual clinical assessments, in 98 patients (age, 46.3+/-15.4 years, 71.4% male) referred from two specialist hypertrophic cardiomyopathy clinics. Cardiac magnetic resonance assessment included quantifying the degree of fibrosis (i.e., the percentage of the myocardium showing enhancement) 10 min after gadolinium infusion. Symptom-limited exercise testing was used to determine exercise capacity (in metabolic equivalent [MET] units). In 71 patients, the basal N-terminal probrain natriuretic peptide (NT-proBNP) level was also measured.
Results:
Late enhancement was observed on cardiac magnetic resonance in 67 (68.4%) patients. These patients had a lower exercise capacity (8.04+/-3.56 MET vs. 10.41+/-3.57 MET; P=.003). There was an inverse correlation between the percentage of fibrosis and exercise capacity (r=-0.21; P=.044). The best predictor of exercise capacity was the logarithm of the NT-proBNP level (r=-0.5; P< .0001). Multivariate analysis confirmed that age, a history of atrial fibrillation, the basal NT-proBNP level and the presence of fibrosis were independent predictors of exercise capacity (r2 for the model=0.47).
Conclusions:
The observation of areas of late gadolinium enhancement on cardiac magnetic resonance was independently associated with poor exercise capacity in patients with hypertrophic cardiomyopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Imaging Studies for Cardiovascular System IV: CMRI
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be met...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
